S1 Biopharma sets IPO range

S1 Biopharma Inc. (New York, N.Y.) amended its IPO on NASDAQ and plans to sell 2.8 million shares at $12-$14. At $13, the company would raise $35.8 million and be valued at $118.6 million. S1 Biopharma filed to raise up to $40.3 million on Oct. 1 underwritten by MLV. ...